MedPath

Pegzilarginase

Generic Name
Pegzilarginase
Brand Names
Loargys
Drug Type
Biotech
CAS Number
1659310-95-8
Unique Ingredient Identifier
4YV4KW88GD

Overview

Pegzilarginase is under investigation in clinical trial NCT02488044 (A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency).

Background

Pegzilarginase is under investigation in clinical trial NCT02488044 (A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 3
Completed
Posted: 2019/04/19
Sponsor:
Aeglea Biotherapeuti...
Phase 2
Completed
Posted: 2017/12/20
Sponsor:
Aeglea Biotherapeuti...
Phase 1
Completed
Posted: 2017/12/13
Sponsor:
Aeglea Biotherapeuti...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath